IDH1-R132 changes vary according to NPM1 and other mutations status in AML

Leukemia. 2019 Apr;33(4):1043-1047. doi: 10.1038/s41375-018-0299-2. Epub 2019 Jan 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Isocitrate Dehydrogenase / genetics*
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / pathology*
  • Mutation*
  • Nuclear Proteins / genetics*
  • Nucleophosmin
  • Prognosis

Substances

  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin
  • Isocitrate Dehydrogenase
  • IDH1 protein, human